Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.

Vici P, Pizzuti L, Gamucci T, Sergi D, Conti F, Zampa G, Del Medico P, De Vita R, Pozzi M, Botti C, Di Filippo S, Tomao F, Sperduti I, Di Lauro L.

J Cancer. 2014 Apr 25;5(6):398-405. doi: 10.7150/jca.9132. eCollection 2014.

PMID:
24847380
[PubMed]
Free PMC Article
2.

Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational study.

Gamucci T, Michelotti A, Pizzuti L, Mentuccia L, Landucci E, Sperduti I, Di Lauro L, Fabi A, Tonini G, Sini V, Salesi N, Ferrarini I, Vaccaro A, Pavese I, Veltri E, Moscetti L, Marchetti P, Vici P.

J Cancer. 2014 Mar 20;5(5):320-7. doi: 10.7150/jca.8748. eCollection 2014.

PMID:
24723974
[PubMed]
Free PMC Article
3.

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.

Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; “FOLLOW-UP” Study Group.

PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.

PMID:
24714591
[PubMed - in process]
Free PMC Article
4.

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review.

Sperduti I, Vici P, Tinari N, Gamucci T, De Tursi M, Cortese G, Grassadonia A, Iacobelli S, Natoli C.

J Exp Clin Cancer Res. 2013 Nov 11;32:89. doi: 10.1186/1756-9966-32-89. Review.

PMID:
24438135
[PubMed - in process]
Free PMC Article
5.

Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.

Grande R, Corsi D, Mancini R, Gemma D, Ciancola F, Sperduti I, Rossi L, Fabbri A, Diodoro MG, Ruggeri E, Zampa G, Bianchetti S, Gamucci T.

PLoS One. 2013 Dec 5;8(12):e80188. doi: 10.1371/journal.pone.0080188. eCollection 2013.

PMID:
24339871
[PubMed - in process]
Free PMC Article
6.

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

Barni S, Lorusso V, Giordano M, Sogno G, Gamucci T, Santoro A, Passalacqua R, Iaffaioli V, Zilembo N, Mencoboni M, Roselli M, Pappagallo G, Pronzato P.

Med Oncol. 2014 Jan;31(1):797. doi: 10.1007/s12032-013-0797-z. Epub 2013 Dec 5.

PMID:
24307348
[PubMed - in process]
7.

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

La Verde N, Moretti A, Farina G, Dazzani MC, Gamucci T, Borgonovo K, Botta M, Salesi N, Zuradelli M, Pavese I, Barbieri E, Cretella E, Saladino T, Varese P, Traverso ES, Addamo G, Ciccarese M, Rispoli AI, Pellegrino A, Mentuccia L, Girelli S, Piva S, Di Maio M.

Future Oncol. 2013 Dec;9(12):1841-8. doi: 10.2217/fon.13.216.

PMID:
24295414
[PubMed - indexed for MEDLINE]
8.

Optimal tolerability and high efficacy of a modified schedule of lapatinib-capecitabine in advanced breast cancer patients.

Gamucci T, Moscetti L, Mentuccia L, Pizzuti L, Mauri M, Zampa G, Pavese I, Sperduti I, Vaccaro A, Vici P.

J Cancer Res Clin Oncol. 2014 Feb;140(2):221-6. doi: 10.1007/s00432-013-1556-4. Epub 2013 Nov 29.

PMID:
24292401
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.

Silvestris N, Pantano F, Ibrahim T, Gamucci T, De Vita F, Di Palma T, Pedrazzoli P, Barni S, Bernardo A, Febbraro A, Satolli MA, Bertocchi P, Catalano V, Giommoni E, Comandone A, Maiello E, Riccardi F, Ferrara R, Trogu A, Berardi R, Leo S, Bertolini A, Angelini F, Cinieri S, Russo A, Pisconti S, Brunetti AE, Azzariti A, Santini D.

PLoS One. 2013 Oct 28;8(10):e74402. doi: 10.1371/journal.pone.0074402. eCollection 2013.

PMID:
24204569
[PubMed - in process]
Free PMC Article
10.

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer.

Vaccaro V, Bria E, Sperduti I, Gelibter A, Moscetti L, Mansueto G, Ruggeri EM, Gamucci T, Cognetti F, Milella M.

World J Gastroenterol. 2013 Jul 28;19(28):4511-9. doi: 10.3748/wjg.v19.i28.4511.

PMID:
23901226
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?

Grande R, Gemma D, Sperduti I, Gelibter A, Giampaolo MA, Trombetta G, Nelli F, Gamucci T.

Springerplus. 2013 Apr 25;2(1):185. Print 2013 Dec.

PMID:
23667824
[PubMed]
Free PMC Article
12.

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.

Natoli C, Vici P, Sperduti I, Grassadonia A, Bisagni G, Tinari N, Michelotti A, Zampa G, Gori S, Moscetti L, De Tursi M, Panebianco M, Mauri M, Ferrarini I, Pizzuti L, Ficorella C, Samaritani R, Mentuccia L, Iacobelli S, Gamucci T.

J Cancer Res Clin Oncol. 2013 Jul;139(7):1229-40. doi: 10.1007/s00432-013-1436-y. Epub 2013 Apr 20.

PMID:
23604446
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study.

Moscetti L, Nelli F, Fabbri MA, Sperduti I, Alesini D, Cortesi E, Gemma D, Gamucci T, Grande R, Pavese I, Franco D, Ruggeri EM.

Invest New Drugs. 2013 Aug;31(4):1035-43. doi: 10.1007/s10637-013-9936-9. Epub 2013 Feb 17.

PMID:
23417697
[PubMed - indexed for MEDLINE]
14.

Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis.

Gamucci T, Vaccaro A, Ciancola F, Pizzuti L, Sperduti I, Moscetti L, Longo F, Fabbri MA, Giampaolo MA, Mentuccia L, Di Lauro L, Vici P.

J Cancer Res Clin Oncol. 2013 May;139(5):853-60. doi: 10.1007/s00432-013-1388-2. Epub 2013 Feb 15.

PMID:
23411686
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.

Bisagni G, Musolino A, Panebianco M, De Matteis A, Nuzzo F, Ardizzoni A, Gori S, Gamucci T, Passalacqua R, Gnoni R, Moretti G, Boni C.

Cancer Chemother Pharmacol. 2013 Apr;71(4):1051-7. doi: 10.1007/s00280-013-2100-6. Epub 2013 Feb 3.

PMID:
23377310
[PubMed - indexed for MEDLINE]
16.

Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study.

Grande R, Narducci F, Bianchetti S, Mansueto G, Gemma D, Sperduti I, Trombetta G, Angelini F, Gamucci T.

Support Care Cancer. 2013 Jun;21(6):1691-5. doi: 10.1007/s00520-012-1715-1. Epub 2013 Jan 13.

PMID:
23314653
[PubMed - indexed for MEDLINE]
17.

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study.

Gori S, Clavarezza M, Siena S, Foglietta J, Tarenzi E, Giordano M, Molino A, Graiff C, Fusco V, Alabiso O, Baldini E, Gamucci T, Altavilla G, Dondi D, Venturini M.

BMC Cancer. 2012 Apr 30;12:158. doi: 10.1186/1471-2407-12-158.

PMID:
22545982
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer.

Gori S, Montemurro F, Spazzapan S, Metro G, Foglietta J, Bisagni G, Ferzi A, Silva RR, Gamucci T, Clavarezza M, Stocchi L, Fabi A, Cognetti F, Torrisi E, Crivellari D.

Ann Oncol. 2012 Jun;23(6):1436-41. doi: 10.1093/annonc/mdr474. Epub 2011 Oct 29.

PMID:
22039084
[PubMed - indexed for MEDLINE]
Free Article
19.

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.

Gridelli C, Gallo C, Morabito A, Iaffaioli RV, Favaretto A, Isa L, Barbera S, Gamucci T, Ceribelli A, Filipazzi V, Maione P, Rossi A, Barletta E, Signoriello S, De Maio E, Piccirillo MC, Di Maio M, Rocco G, Vecchione A, Perrone F; G-STEP Investigators.

J Thorac Oncol. 2012 Jan;7(1):233-42. doi: 10.1097/JTO.0b013e318233d6c2.

PMID:
22031232
[PubMed - indexed for MEDLINE]
20.

A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.

Grossi F, de Marinis F, Gebbia V, Riccardi F, Caffo O, Gamucci T, Ferraù F, Nardi M, Moscetti L, Boni L, Dondi D, Galligioni E.

Cancer Chemother Pharmacol. 2012 Feb;69(2):369-75. doi: 10.1007/s00280-011-1710-0. Epub 2011 Jul 21.

PMID:
21833588
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk